Description

Aqualane, a leading clinical research company, proudly announces its expansion with the opening of a new Phase 1 clinical research unit. This state-of-the-art facility will accommodate long-term stays and overnight clinical trials, significantly enhancing the scope of treatments and therapies available to the Southwest Florida community. Since its inception in 2022, Aqualane has built a reputation for excellence in clinical research, following a longstanding tradition of clinical investigation from Collier Neurologic Specialists, where it operated under the guidance of principal investigators Dr. William Justiz and Dr. Matthew Baker. Under the leadership of CEO Kelly Calistri, Aqualane has been dedicated to advancing medical knowledge and patient care through rigorous research and innovative approaches. The new Phase 1 unit, set to open on August 21st at 12:00 PM, is located at 3200 Bailey Lane, Suite 180, Naples, FL 34105. This expansion represents a significant milestone for Aqualane, providing advanced facilities designed to support comprehensive clinical trials and contribute to the development of new therapies. Clinical research is essential for advancing medical science and improving patient outcomes. By participating in clinical trials, patients gain access to cutting-edge treatments while contributing to the development of new therapies that can benefit future generations. Aqualane’s expansion underscores its commitment to this crucial field, enhancing its capacity to conduct innovative research and deliver new treatments to those in need. The opening event will offer an opportunity to tour the new facility and learn more about Aqualane’s commitment to advancing healthcare through clinical research. For additional information or to RSVP for the event, please contact Head of Business Development, Darious Davis, at darious@aqualaneresearch.com or call 239-529-6780.